世界のグラム陽性菌感染症治療薬市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global Gram-positive Bacterial Infection Drugs Market 2021 by Company, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-107A12308
• 出版社/出版日：GlobalInfoResearch / 2021年7月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、105ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当調査資料では、グラム陽性菌感染症治療薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。グラム陽性菌感染症治療薬の種類別市場規模（抗生物質、抗真菌剤、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・グラム陽性菌感染症治療薬の市場概要
・企業情報（企業概要、製品概要、販売量、価格、売上）：Pfizer、Sanofi、GlaxoSmithKline、Bayer、Bristol-Myers Squibb、Novartis、Merck、AstraZeneca、Allergan、Theravance Biopharma
・企業別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年：抗生物質、抗真菌剤、その他
・用途別分析2016年-2026年：病院薬局、小売薬局、オンライン薬局
・グラム陽性菌感染症治療薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ
・グラム陽性菌感染症治療薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア
・グラム陽性菌感染症治療薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア
・グラム陽性菌感染症治療薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン
・グラム陽性菌感染症治療薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Gram-positive Bacterial Infection Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Gram-positive Bacterial Infection Drugs size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Gram-positive Bacterial Infection Drugs market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Gram-positive Bacterial Infection Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Antibiotic
Antifungal
Others

Market segment by Application, can be divided into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Market segment by players, this report covers
Pfizer
Sanofi
GlaxoSmithKline
Bayer
Bristol-Myers Squibb
Novartis
Merck
AstraZeneca
Allergan
Theravance Biopharma

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

レポート目次

1 Market Overview
1.1 Product Overview and Scope of Gram-positive Bacterial Infection Drugs
1.2 Classification of Gram-positive Bacterial Infection Drugs by Type
1.2.1 Overview: Global Gram-positive Bacterial Infection Drugs Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Gram-positive Bacterial Infection Drugs Revenue Market Share by Type in 2020
1.2.3 Antibiotic
1.2.4 Antifungal
1.2.5 Others
1.3 Global Gram-positive Bacterial Infection Drugs Market by Application
1.3.1 Overview: Global Gram-positive Bacterial Infection Drugs Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Gram-positive Bacterial Infection Drugs Market Size & Forecast
1.5 Global Gram-positive Bacterial Infection Drugs Market Size and Forecast by Region
1.5.1 Global Gram-positive Bacterial Infection Drugs Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Gram-positive Bacterial Infection Drugs Market Size by Region, (2016-2021)
1.5.3 North America Gram-positive Bacterial Infection Drugs Market Size and Prospect (2016-2026)
1.5.4 Europe Gram-positive Bacterial Infection Drugs Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Gram-positive Bacterial Infection Drugs Market Size and Prospect (2016-2026)
1.5.6 South America Gram-positive Bacterial Infection Drugs Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Gram-positive Bacterial Infection Drugs Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Gram-positive Bacterial Infection Drugs Market Drivers
1.6.2 Gram-positive Bacterial Infection Drugs Market Restraints
1.6.3 Gram-positive Bacterial Infection Drugs Trends Analysis
2 Company Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Gram-positive Bacterial Infection Drugs Product and Solutions
2.1.4 Pfizer Gram-positive Bacterial Infection Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Pfizer Recent Developments and Future Plans
2.2 Sanofi
2.2.1 Sanofi Details
2.2.2 Sanofi Major Business
2.2.3 Sanofi Gram-positive Bacterial Infection Drugs Product and Solutions
2.2.4 Sanofi Gram-positive Bacterial Infection Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Sanofi Recent Developments and Future Plans
2.3 GlaxoSmithKline
2.3.1 GlaxoSmithKline Details
2.3.2 GlaxoSmithKline Major Business
2.3.3 GlaxoSmithKline Gram-positive Bacterial Infection Drugs Product and Solutions
2.3.4 GlaxoSmithKline Gram-positive Bacterial Infection Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 GlaxoSmithKline Recent Developments and Future Plans
2.4 Bayer
2.4.1 Bayer Details
2.4.2 Bayer Major Business
2.4.3 Bayer Gram-positive Bacterial Infection Drugs Product and Solutions
2.4.4 Bayer Gram-positive Bacterial Infection Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Bayer Recent Developments and Future Plans
2.5 Bristol-Myers Squibb
2.5.1 Bristol-Myers Squibb Details
2.5.2 Bristol-Myers Squibb Major Business
2.5.3 Bristol-Myers Squibb Gram-positive Bacterial Infection Drugs Product and Solutions
2.5.4 Bristol-Myers Squibb Gram-positive Bacterial Infection Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Bristol-Myers Squibb Recent Developments and Future Plans
2.6 Novartis
2.6.1 Novartis Details
2.6.2 Novartis Major Business
2.6.3 Novartis Gram-positive Bacterial Infection Drugs Product and Solutions
2.6.4 Novartis Gram-positive Bacterial Infection Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Novartis Recent Developments and Future Plans
2.7 Merck
2.7.1 Merck Details
2.7.2 Merck Major Business
2.7.3 Merck Gram-positive Bacterial Infection Drugs Product and Solutions
2.7.4 Merck Gram-positive Bacterial Infection Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Merck Recent Developments and Future Plans
2.8 AstraZeneca
2.8.1 AstraZeneca Details
2.8.2 AstraZeneca Major Business
2.8.3 AstraZeneca Gram-positive Bacterial Infection Drugs Product and Solutions
2.8.4 AstraZeneca Gram-positive Bacterial Infection Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 AstraZeneca Recent Developments and Future Plans
2.9 Allergan
2.9.1 Allergan Details
2.9.2 Allergan Major Business
2.9.3 Allergan Gram-positive Bacterial Infection Drugs Product and Solutions
2.9.4 Allergan Gram-positive Bacterial Infection Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Allergan Recent Developments and Future Plans
2.10 Theravance Biopharma
2.10.1 Theravance Biopharma Details
2.10.2 Theravance Biopharma Major Business
2.10.3 Theravance Biopharma Gram-positive Bacterial Infection Drugs Product and Solutions
2.10.4 Theravance Biopharma Gram-positive Bacterial Infection Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Theravance Biopharma Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Gram-positive Bacterial Infection Drugs Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Gram-positive Bacterial Infection Drugs Players Market Share
3.2.2 Top 10 Gram-positive Bacterial Infection Drugs Players Market Share
3.2.3 Market Competition Trend
3.3 Gram-positive Bacterial Infection Drugs Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Gram-positive Bacterial Infection Drugs Revenue and Market Share by Type (2016-2021)
4.2 Global Gram-positive Bacterial Infection Drugs Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Gram-positive Bacterial Infection Drugs Revenue Market Share by Application (2016-2021)
5.2 Gram-positive Bacterial Infection Drugs Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Gram-positive Bacterial Infection Drugs Revenue by Type (2016-2026)
6.2 North America Gram-positive Bacterial Infection Drugs Revenue by Application (2016-2026)
6.3 North America Gram-positive Bacterial Infection Drugs Market Size by Country
6.3.1 North America Gram-positive Bacterial Infection Drugs Revenue by Country (2016-2026)
6.3.2 United States Gram-positive Bacterial Infection Drugs Market Size and Forecast (2016-2026)
6.3.3 Canada Gram-positive Bacterial Infection Drugs Market Size and Forecast (2016-2026)
6.3.4 Mexico Gram-positive Bacterial Infection Drugs Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Gram-positive Bacterial Infection Drugs Revenue by Type (2016-2026)
7.2 Europe Gram-positive Bacterial Infection Drugs Revenue by Application (2016-2026)
7.3 Europe Gram-positive Bacterial Infection Drugs Market Size by Country
7.3.1 Europe Gram-positive Bacterial Infection Drugs Revenue by Country (2016-2026)
7.3.2 Germany Gram-positive Bacterial Infection Drugs Market Size and Forecast (2016-2026)
7.3.3 France Gram-positive Bacterial Infection Drugs Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Gram-positive Bacterial Infection Drugs Market Size and Forecast (2016-2026)
7.3.5 Russia Gram-positive Bacterial Infection Drugs Market Size and Forecast (2016-2026)
7.3.6 Italy Gram-positive Bacterial Infection Drugs Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Gram-positive Bacterial Infection Drugs Revenue by Type (2016-2026)
8.2 Asia-Pacific Gram-positive Bacterial Infection Drugs Revenue by Application (2016-2026)
8.3 Asia-Pacific Gram-positive Bacterial Infection Drugs Market Size by Region
8.3.1 Asia-Pacific Gram-positive Bacterial Infection Drugs Revenue by Region (2016-2026)
8.3.2 China Gram-positive Bacterial Infection Drugs Market Size and Forecast (2016-2026)
8.3.3 Japan Gram-positive Bacterial Infection Drugs Market Size and Forecast (2016-2026)
8.3.4 South Korea Gram-positive Bacterial Infection Drugs Market Size and Forecast (2016-2026)
8.3.5 India Gram-positive Bacterial Infection Drugs Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Gram-positive Bacterial Infection Drugs Market Size and Forecast (2016-2026)
8.3.7 Australia Gram-positive Bacterial Infection Drugs Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Gram-positive Bacterial Infection Drugs Revenue by Type (2016-2026)
9.2 South America Gram-positive Bacterial Infection Drugs Revenue by Application (2016-2026)
9.3 South America Gram-positive Bacterial Infection Drugs Market Size by Country
9.3.1 South America Gram-positive Bacterial Infection Drugs Revenue by Country (2016-2026)
9.3.2 Brazil Gram-positive Bacterial Infection Drugs Market Size and Forecast (2016-2026)
9.3.3 Argentina Gram-positive Bacterial Infection Drugs Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Gram-positive Bacterial Infection Drugs Revenue by Type (2016-2026)
10.2 Middle East & Africa Gram-positive Bacterial Infection Drugs Revenue by Application (2016-2026)
10.3 Middle East & Africa Gram-positive Bacterial Infection Drugs Market Size by Country
10.3.1 Middle East & Africa Gram-positive Bacterial Infection Drugs Revenue by Country (2016-2026)
10.3.2 Turkey Gram-positive Bacterial Infection Drugs Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Gram-positive Bacterial Infection Drugs Market Size and Forecast (2016-2026)
10.3.4 UAE Gram-positive Bacterial Infection Drugs Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Gram-positive Bacterial Infection Drugs Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Gram-positive Bacterial Infection Drugs Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Gram-positive Bacterial Infection Drugs Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Gram-positive Bacterial Infection Drugs Revenue (USD Million) by Region (2016-2021)
Table 5. Global Gram-positive Bacterial Infection Drugs Revenue Market Share by Region (2021-2026)
Table 6. Pfizer Corporate Information, Head Office, and Major Competitors
Table 7. Pfizer Major Business
Table 8. Pfizer Gram-positive Bacterial Infection Drugs Product and Solutions
Table 9. Pfizer Gram-positive Bacterial Infection Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Sanofi Corporate Information, Head Office, and Major Competitors
Table 11. Sanofi Major Business
Table 12. Sanofi Gram-positive Bacterial Infection Drugs Product and Solutions
Table 13. Sanofi Gram-positive Bacterial Infection Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. GlaxoSmithKline Corporate Information, Head Office, and Major Competitors
Table 15. GlaxoSmithKline Major Business
Table 16. GlaxoSmithKline Gram-positive Bacterial Infection Drugs Product and Solutions
Table 17. GlaxoSmithKline Gram-positive Bacterial Infection Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Bayer Corporate Information, Head Office, and Major Competitors
Table 19. Bayer Major Business
Table 20. Bayer Gram-positive Bacterial Infection Drugs Product and Solutions
Table 21. Bayer Gram-positive Bacterial Infection Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Bristol-Myers Squibb Corporate Information, Head Office, and Major Competitors
Table 23. Bristol-Myers Squibb Major Business
Table 24. Bristol-Myers Squibb Gram-positive Bacterial Infection Drugs Product and Solutions
Table 25. Bristol-Myers Squibb Gram-positive Bacterial Infection Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Novartis Corporate Information, Head Office, and Major Competitors
Table 27. Novartis Major Business
Table 28. Novartis Gram-positive Bacterial Infection Drugs Product and Solutions
Table 29. Novartis Gram-positive Bacterial Infection Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Merck Corporate Information, Head Office, and Major Competitors
Table 31. Merck Major Business
Table 32. Merck Gram-positive Bacterial Infection Drugs Product and Solutions
Table 33. Merck Gram-positive Bacterial Infection Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. AstraZeneca Corporate Information, Head Office, and Major Competitors
Table 35. AstraZeneca Major Business
Table 36. AstraZeneca Gram-positive Bacterial Infection Drugs Product and Solutions
Table 37. AstraZeneca Gram-positive Bacterial Infection Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Allergan Corporate Information, Head Office, and Major Competitors
Table 39. Allergan Major Business
Table 40. Allergan Gram-positive Bacterial Infection Drugs Product and Solutions
Table 41. Allergan Gram-positive Bacterial Infection Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Theravance Biopharma Corporate Information, Head Office, and Major Competitors
Table 43. Theravance Biopharma Major Business
Table 44. Theravance Biopharma Gram-positive Bacterial Infection Drugs Product and Solutions
Table 45. Theravance Biopharma Gram-positive Bacterial Infection Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Global Gram-positive Bacterial Infection Drugs Revenue (USD Million) by Players (2019-2021)
Table 47. Global Gram-positive Bacterial Infection Drugs Revenue Share by Players (2019-2021)
Table 48. Breakdown of Gram-positive Bacterial Infection Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 49. Gram-positive Bacterial Infection Drugs Players Head Office, Products and Services Provided
Table 50. Gram-positive Bacterial Infection Drugs Mergers & Acquisitions in the Past Five Years
Table 51. Gram-positive Bacterial Infection Drugs New Entrants and Expansion Plans
Table 52. Global Gram-positive Bacterial Infection Drugs Revenue (USD Million) by Type (2016-2021)
Table 53. Global Gram-positive Bacterial Infection Drugs Revenue Share by Type (2016-2021)
Table 54. Global Gram-positive Bacterial Infection Drugs Revenue Forecast by Type (2021-2026)
Table 55. Global Gram-positive Bacterial Infection Drugs Revenue by Application (2016-2021)
Table 56. Global Gram-positive Bacterial Infection Drugs Revenue Forecast by Application (2021-2026)
Table 57. North America Gram-positive Bacterial Infection Drugs Revenue by Type (2016-2021) & (USD Million)
Table 58. North America Gram-positive Bacterial Infection Drugs Revenue by Type (2021-2026) & (USD Million)
Table 59. North America Gram-positive Bacterial Infection Drugs Revenue by Application (2016-2021) & (USD Million)
Table 60. North America Gram-positive Bacterial Infection Drugs Revenue by Application (2021-2026) & (USD Million)
Table 61. North America Gram-positive Bacterial Infection Drugs Revenue by Country (2016-2021) & (USD Million)
Table 62. North America Gram-positive Bacterial Infection Drugs Revenue by Country (2021-2026) & (USD Million)
Table 63. Europe Gram-positive Bacterial Infection Drugs Revenue by Type (2016-2021) & (USD Million)
Table 64. Europe Gram-positive Bacterial Infection Drugs Revenue by Type (2021-2026) & (USD Million)
Table 65. Europe Gram-positive Bacterial Infection Drugs Revenue by Application (2016-2021) & (USD Million)
Table 66. Europe Gram-positive Bacterial Infection Drugs Revenue by Application (2021-2026) & (USD Million)
Table 67. Europe Gram-positive Bacterial Infection Drugs Revenue by Country (2016-2021) & (USD Million)
Table 68. Europe Gram-positive Bacterial Infection Drugs Revenue by Country (2021-2026) & (USD Million)
Table 69. Asia-Pacific Gram-positive Bacterial Infection Drugs Revenue by Type (2016-2021) & (USD Million)
Table 70. Asia-Pacific Gram-positive Bacterial Infection Drugs Revenue by Type (2021-2026) & (USD Million)
Table 71. Asia-Pacific Gram-positive Bacterial Infection Drugs Revenue by Application (2016-2021) & (USD Million)
Table 72. Asia-Pacific Gram-positive Bacterial Infection Drugs Revenue by Application (2021-2026) & (USD Million)
Table 73. Asia-Pacific Gram-positive Bacterial Infection Drugs Revenue by Region (2016-2021) & (USD Million)
Table 74. Asia-Pacific Gram-positive Bacterial Infection Drugs Revenue by Region (2021-2026) & (USD Million)
Table 75. South America Gram-positive Bacterial Infection Drugs Revenue by Type (2016-2021) & (USD Million)
Table 76. South America Gram-positive Bacterial Infection Drugs Revenue by Type (2021-2026) & (USD Million)
Table 77. South America Gram-positive Bacterial Infection Drugs Revenue by Application (2016-2021) & (USD Million)
Table 78. South America Gram-positive Bacterial Infection Drugs Revenue by Application (2021-2026) & (USD Million)
Table 79. South America Gram-positive Bacterial Infection Drugs Revenue by Country (2016-2021) & (USD Million)
Table 80. South America Gram-positive Bacterial Infection Drugs Revenue by Country (2021-2026) & (USD Million)
Table 81. Middle East & Africa Gram-positive Bacterial Infection Drugs Revenue by Type (2016-2021) & (USD Million)
Table 82. Middle East & Africa Gram-positive Bacterial Infection Drugs Revenue by Type (2021-2026) & (USD Million)
Table 83. Middle East & Africa Gram-positive Bacterial Infection Drugs Revenue by Application (2016-2021) & (USD Million)
Table 84. Middle East & Africa Gram-positive Bacterial Infection Drugs Revenue by Application (2021-2026) & (USD Million)
Table 85. Middle East & Africa Gram-positive Bacterial Infection Drugs Revenue by Country (2016-2021) & (USD Million)
Table 86. Middle East & Africa Gram-positive Bacterial Infection Drugs Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Gram-positive Bacterial Infection Drugs Picture
Figure 2. Global Gram-positive Bacterial Infection Drugs Revenue Market Share by Type in 2020
Figure 3. Antibiotic
Figure 4. Antifungal
Figure 5. Others
Figure 6. Gram-positive Bacterial Infection Drugs Revenue Market Share by Application in 2020
Figure 7. Hospital Pharmacies Picture
Figure 8. Retail Pharmacies Picture
Figure 9. Online Pharmacies Picture
Figure 10. Global Gram-positive Bacterial Infection Drugs Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 11. Global Gram-positive Bacterial Infection Drugs Revenue and Forecast (2016-2026) & (USD Million)
Figure 12. Global Gram-positive Bacterial Infection Drugs Revenue Market Share by Region (2016-2026)
Figure 13. Global Gram-positive Bacterial Infection Drugs Revenue Market Share by Region in 2020
Figure 14. North America Gram-positive Bacterial Infection Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Europe Gram-positive Bacterial Infection Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Asia-Pacific Gram-positive Bacterial Infection Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. South America Gram-positive Bacterial Infection Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Middle East and Africa Gram-positive Bacterial Infection Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Gram-positive Bacterial Infection Drugs Market Drivers
Figure 20. Gram-positive Bacterial Infection Drugs Market Restraints
Figure 21. Gram-positive Bacterial Infection Drugs Market Trends
Figure 22. Pfizer Recent Developments and Future Plans
Figure 23. Sanofi Recent Developments and Future Plans
Figure 24. GlaxoSmithKline Recent Developments and Future Plans
Figure 25. Bayer Recent Developments and Future Plans
Figure 26. Bristol-Myers Squibb Recent Developments and Future Plans
Figure 27. Novartis Recent Developments and Future Plans
Figure 28. Merck Recent Developments and Future Plans
Figure 29. AstraZeneca Recent Developments and Future Plans
Figure 30. Allergan Recent Developments and Future Plans
Figure 31. Theravance Biopharma Recent Developments and Future Plans
Figure 32. Global Gram-positive Bacterial Infection Drugs Revenue Share by Players in 2020
Figure 33. Gram-positive Bacterial Infection Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 34. Global Top 3 Players Gram-positive Bacterial Infection Drugs Revenue Market Share in 2020
Figure 35. Global Top 10 Players Gram-positive Bacterial Infection Drugs Revenue Market Share in 2020
Figure 36. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 37. Global Gram-positive Bacterial Infection Drugs Revenue Share by Type in 2020
Figure 38. Global Gram-positive Bacterial Infection Drugs Market Share Forecast by Type (2021-2026)
Figure 39. Global Gram-positive Bacterial Infection Drugs Revenue Share by Application in 2020
Figure 40. Global Gram-positive Bacterial Infection Drugs Market Share Forecast by Application (2021-2026)
Figure 41. North America Gram-positive Bacterial Infection Drugs Sales Market Share by Type (2016-2026)
Figure 42. North America Gram-positive Bacterial Infection Drugs Sales Market Share by Application (2016-2026)
Figure 43. North America Gram-positive Bacterial Infection Drugs Revenue Market Share by Country (2016-2026)
Figure 44. United States Gram-positive Bacterial Infection Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Canada Gram-positive Bacterial Infection Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Mexico Gram-positive Bacterial Infection Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Europe Gram-positive Bacterial Infection Drugs Sales Market Share by Type (2016-2026)
Figure 48. Europe Gram-positive Bacterial Infection Drugs Sales Market Share by Application (2016-2026)
Figure 49. Europe Gram-positive Bacterial Infection Drugs Revenue Market Share by Country (2016-2026)
Figure 50. Germany Gram-positive Bacterial Infection Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. France Gram-positive Bacterial Infection Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. United Kingdom Gram-positive Bacterial Infection Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Russia Gram-positive Bacterial Infection Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Italy Gram-positive Bacterial Infection Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Asia-Pacific Gram-positive Bacterial Infection Drugs Sales Market Share by Type (2016-2026)
Figure 56. Asia-Pacific Gram-positive Bacterial Infection Drugs Sales Market Share by Application (2016-2026)
Figure 57. Asia-Pacific Gram-positive Bacterial Infection Drugs Revenue Market Share by Region (2016-2026)
Figure 58. China Gram-positive Bacterial Infection Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Japan Gram-positive Bacterial Infection Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. South Korea Gram-positive Bacterial Infection Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. India Gram-positive Bacterial Infection Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Southeast Asia Gram-positive Bacterial Infection Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Australia Gram-positive Bacterial Infection Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. South America Gram-positive Bacterial Infection Drugs Sales Market Share by Type (2016-2026)
Figure 65. South America Gram-positive Bacterial Infection Drugs Sales Market Share by Application (2016-2026)
Figure 66. South America Gram-positive Bacterial Infection Drugs Revenue Market Share by Country (2016-2026)
Figure 67. Brazil Gram-positive Bacterial Infection Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Argentina Gram-positive Bacterial Infection Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Middle East and Africa Gram-positive Bacterial Infection Drugs Sales Market Share by Type (2016-2026)
Figure 70. Middle East and Africa Gram-positive Bacterial Infection Drugs Sales Market Share by Application (2016-2026)
Figure 71. Middle East and Africa Gram-positive Bacterial Infection Drugs Revenue Market Share by Country (2016-2026)
Figure 72. Turkey Gram-positive Bacterial Infection Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Saudi Arabia Gram-positive Bacterial Infection Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. UAE Gram-positive Bacterial Infection Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Methodology
Figure 76. Research Process and Data Source

Global Gram-positive Bacterial Infection Drugs Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR09F3062 2019年9月16日 121Pages
本調査レポートは、グラム陽性菌感染症薬の世界市場について調べ、まとめました。種類別セグメントは、抗生物質、抗真菌剤、その他等、用途別セグメントは、病院薬局、小売薬局、オンライン薬局等に区分しました。グラム陽性菌感染症薬の世界市場概観、企業動向、企業別グラム陽性菌感染症薬シェア、市場規模推移、市場規模...

世界の細菌性眼感染症治療薬市場予測（～2024年）：メーカー別、地域別、種類・用途別

Global Bacterial Eye Infection Therapeutics Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
B-GIR09F0476 2019年11月4日 124Pages
本調査レポートは、細菌性眼感染症治療薬の世界市場について調べ、まとめました。種類別セグメントは、軟膏、目薬、医薬品等、用途別セグメントは、病院薬局、小売薬局、その他等に区分しました。細菌性眼感染症治療薬の世界市場概観、メーカー動向、メーカー別細菌性眼感染症治療薬シェア、市場規模推移、市場規模予測（2...

世界のサイトメガロウイルス（HHV-5）感染症治療薬市場 2021：企業別、地域別、種類・用途別

Global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market 2021 by Company, Regions, Type and Application, Forecast to 2026
GIR-107A12203 2021年7月 123Pages
当調査資料では、サイトメガロウイルス（HHV-5）感染症治療薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。サイトメガロウイルス（HHV-5）感染症治療薬の種類別市場規模（経口薬、注射）、用途別市場規模（病院、クリニック、その他）、地域別市場規模（北...

世界の腸内細菌科感染症薬市場 2021：企業別、地域別、種類・用途別

Global Enterobacteriaceae Infection Drug Market 2021 by Company, Regions, Type and Application, Forecast to 2026
GIR-107A12261 2021年7月 109Pages
当調査資料では、腸内細菌科感染症薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。腸内細菌科感染症薬の種類別市場規模（ベータラクタム薬、カルバペネム薬、フルオロキノロン薬、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、地域別市場規模（...

世界の細菌感染症診断市場 2021：企業別、地域別、種類・用途別

Global Bacterial Disease Diagnostics Market 2021 by Company, Regions, Type and Application, Forecast to 2026
GIR-107A12081 2021年7月 109Pages
当調査資料では、細菌感染症診断のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。細菌感染症診断の種類別市場規模（機器、消耗品、その他）、用途別市場規模（臨床、腸チフス、マラリア、結核（TB）、結核性髄膜炎、その他）、地域別市場規模（北米、アメリカ、ヨーロ...

世界の細菌性膣炎治療市場 2021：企業別、地域別、種類・用途別

Global Bacterial Vaginosis Treatment Market 2021 by Company, Regions, Type and Application, Forecast to 2026
GIR-107A12082 2021年7月 129Pages
当調査資料では、細菌性膣炎治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。細菌性膣炎治療の種類別市場規模（外科的治療、薬物治療）、用途別市場規模（病院、専門治療センター、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南...

世界の気道陽圧（PAP）デバイス市場 2021：企業別、地域別、種類・用途別

Global Positive Airway Pressure (PAP) Devices Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-107A13523 2021年7月 87Pages
当調査資料では、気道陽圧（PAP）デバイスのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。気道陽圧（PAP）デバイスの種類別市場規模（APAP、CPAP、BPAP）、用途別市場規模（睡眠研究所＆病院、在宅ケア/個人用）、地域別市場規模（北米、アメリカ、...

世界のマールブルグウイルス感染症市場 2021：企業別、地域別、種類・用途別

Global Marburgvirus Infection Market 2021 by Company, Regions, Type and Application, Forecast to 2026
GIR-107A12449 2021年7月 94Pages
当調査資料では、マールブルグウイルス感染症のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。マールブルグウイルス感染症の種類別市場規模（エリトラン四ナトリウム、AR-12、ARD-5、AVI-7288、その他）、用途別市場規模（病院、クリニック、その他）...

世界の呼気終末陽圧（PEP）デバイス市場 2021：企業別、地域別、種類・用途別

Global Positive Expiratory Pressure (PEP) Devices Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-107A13525 2021年7月 103Pages
当調査資料では、呼気終末陽圧（PEP）デバイスのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。呼気終末陽圧（PEP）デバイスの種類別市場規模（高圧PEP（26-102cm H2O）デバイス、低圧PEP（5-20cm H2O）デバイス）、用途別市場規...

サイトメガロウイルス（HHV-5）感染症治療薬の世界市場 2019年版：種類別（経口薬、注射）、用途別（病院、診療所、その他）

Global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market 2019 by Company, Regions, Type and Application, Forecast to 2024
C-GIR20G2631 2019年12月30日 120Pages
「サイトメガロウイルス（HHV-5）感染症治療薬の世界市場2019年」は、グローバルにおけるサイトメガロウイルス（HHV-5）感染症治療薬市場を展望するレポートです。サイトメガロウイルス（HHV-5）感染症治療薬のグローバル市場概観、企業動向、企業別シェア、市場規模推移、市場規模予測（2019年-2...

世界のグラム陽性菌感染症薬市場予測（～2024年）：企業別、地域別、種類・用途別 Gram-positive bacteria are those that are stained dark blue or violet by Gram staining. They are a major class of bacteria that cause various infections in humans. Scope of the Report: The global Gram-positive Bacterial Infection Drugs market is valued at xx million USD in 2018 and is expected to re…
世界の細菌性眼感染症治療薬市場予測（～2024年）：メーカー別、地域別、種類・用途別 It is a serious eye infection caused by several types of bacteria. Scope of the Report: The worldwide market for Bacterial Eye Infection Therapeutics is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a…
サイトメガロウイルス（HHV-5）感染症治療薬の世界市場 2019年版：種類別（経口薬、注射）、用途別（病院、診療所、その他） Description Scope of the Report: The global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in f…
世界のサイトメガロウイルス（HHV-5）感染症治療薬市場 2021：企業別、地域別、種類・用途別 The Cytomegalovirus（HHV-5）Infection Therapeutic Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain o…
世界の眼感染症薬市場予測（～2024年）：メーカー別、地域別、種類・用途別 Scope of the Report: The worldwide market for Eye Infection Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Eye Infection Drugs…